Synairgen Share Discussion Threads

[amaretto1] 23/7/2020 21:06

They have a large position in C4XD Long ... i followed them in Clive Dix involved ...He's bought shed loads of stock .. way way above current share price Worth a look.

[andymunchkin] 23/7/2020 20:59

Healthcare billionaire and former Teva chairman Philip Frost has agreed to settle stock “pump-and-dump” charges with the Securities and Exchange Commission by paying $5.5 million.

Frost, without admitting or denying the SEC allegations, agreed to pay about $5.5 million in penalty and repayment of alleged illegal gains. His Miami-based biopharmaceutical and diagnostic company, Opko Health, will pay a $100,000 fine.

“We have reached agreement with the SEC that will end a potentially expensive, contentious and time-consuming litigation and I am happy that we can focus on an exciting and productive 2019 for Opko Health,” said Frost, a legendary biopharma entrepreneur who served as Teva’s chairman from March 2010 to late 2014.

Frost was one of 10 people and Opko one of 10 related companies charged by the SEC on Sept. 7, 2018, over alleged “pump-and-dump” schemes. The people and companies were said to have manipulated three companies’ stock prices from 2013 to 2018 and reaped $27 million in proceeds, according to the SEC (PDF).

The group allegedly bought large quantities of so-called “penny stocks” at steep discounts, used dubious promotion campaigns such as blog posts to inflate their prices without truthfully disclosing financial ties, and then sold their shares at high prices.

Frost was involved in two schemes, the SEC said. Based on SEC document references, the two companies can be identified as Biozone Pharmaceuticals, which makes OTC and consumer health products and was acquired by Cocrystal Pharma in a 2014 reverse merger, and cancer biotech MabVax Therapeutics.

In Biozone’s case, for example, a consortium Frost was part of once controlled nearly three-quarters of the company, a fact that wasn't disclosed in its annual report to the SEC, said the agency. Before the pump and dump, they allegedly paid John Ford to promote Biozone in a Seeking Alpha article (since removed from the website) stressing Frost’s involvement and “rosy prospects” for the company’s R&D. After Ford’s bullish “analysis” run in September 2013, Biozone’s stock price increased from about $0.48 in August to a high of $0.97 on Oct. 17 of that year. All told, the group sold their shares for about $9.26 million.

The story was largely the same for MabVax. Led by South Florida investor Barry Honig, whom the SEC called the scheme’s “primary strategist,” Frost and others took a majority stake in the biotech, boosted its outlook through a promotional article on Seeking Alpha in 2015 and sold shares for total proceeds of over $5.5 million.

In response to the SEC’s allegations, Frost in September said he was “stunned” by the lawsuit and denied the allegations. “The allegations against me are belied by common sense, my history of supporting promising scientific technology, and the facts,” he said at the time.

Frost, identified by the SEC as “a successful biotech investor,” was a longtime chairman and CEO of Ivax before selling it to Teva for $7.4 billion in 2005. He's held the reins at Opko as CEO and chairman since March 2007 and will remain in those jobs. But with the settlement, he will be restricted from trading penny stocks.

[big brother8] 23/7/2020 20:58

GOOD SHS MY BIUTIFUL PEOPLE.

WE BOUGHT AT 95P AND REVERSED FROM 225P, WITH AVERAGE SHORT OF 210P. NOW WE HAVE CLOSED AND MARCHING TOWARDS 500P.

YES BB TEAM TRIED THEIR LUCK TODAY. CAN'T BLAME US. THE ANTS WILL DEVOUR ANYTHING ON THEIR PATHS. MANY GOOD BRUTHAS HERE REASONED AND SHOWED BIG BRO, HIS WICKED WAY WAS WRONG. PLANET EARTH IS FACING AN EXISTENTIAL THREAT FROM THE WUHAN VIRUS.

IN FACT, OUR GEM NEEDED RECALIBRATION AS IT STALLED. A FLUSH DOWN (TREESHAKE) WAS NECESSARY AND WHOOOOOOOOOSH .


IT'S BEST YOUR LEADER BB GUIDE THE ARMY AND REBELS TOWARDS 500P. WE ARE STRONGER UNITED. BB IS KOMMANDANT ANT'S MARK ANTHONY.

NO SOLDIER IS EVER LEFT BEHIND ENEMY LINE.



BB8
UNUS PRO OMNIBUS, OMNES PRO UNO.
IN BB8 WE TRUST.

[rambutan2] 23/7/2020 20:54

And they bought after the trial results came out ie in their eyes derisked but lots of upside still to come.

[andymunchkin] 23/7/2020 20:54

———;——̵2;—-
milliecusto22 Jul '20 - 00:24 - 10777 of 11054
0 0 1
Only actually trialed on 50 people of which 79% had a success, so 1 in 5 no difference, with a bigger trial those fluctuations can get better or worse, reminds me of the avct bb, ramping galore. No one is spending billions on a trial of 50 people with a 20% fail rate, before I get shouted down the other 50 people had a placebo.
The consideration if a vaccine comes out in autumn, this becomes less beneficial.
———;——-cheersMillie—̵2;—
Umatingytribe23 Jul '20 - 08:36 - 10929 of 11314
0 1 1
Placing has to be imminent. Surely.
--------
------

big brother823 Jul '20 - 17:30 - 118 of 128
0 0 0
ALL GENUINE GAMBLERS




I HAD QUITE A LOT OF DRUGS AND BEEN BOOZING ALL MY NAN'S WHISKY LATELY DUE TO COVID19 AS I WAS VERY DEPRESSED AND THOUGHT EVERYONE WOULD DIE. VERY TRUE.

MY GIRLFRIEND SAKURA WENT BACK TO TOKYO TO PAY MY DEBT TO THE YAKUZA. CAN'T WAIT SHE GETS BACK.
------------------------------------
------------------------------------
big brother823 Jul '20 - 07:16 - 1 of 128
0 0 1
THE SELL SELL SELL SWITCH HAS BEEN PUT INTO OVERDRIVE

KILL KILL KILL



ENJOY THE BLOOD GAME.



BB8
IN BB8 WE TRUST.
big brother823 Jul '20 - 07:19 - 2 of 128
0 0 1
THE PUMPING IS OVER
NOW THE DUMPING IS ABOUT TO GO FAST AND FURIOUS.

GOOLIES, TITTIES AND POOSIES ABOUT TO GET SMASHED.


BB8
IN BB8 WE TRUST.
big brother823 Jul '20 - 07:20 - 3 of 128
0 0 1
GOOD TIME FOR A DISCOUNTE PLACING AT 45P.
--------------------------------------------------------------------
--------------------------------------------------------------------

BB8
IN BB8 WE TRUST.
big brother823 Jul '20 - 07:52 - 4 of 128
0 0 1
BIG RED DAY TODAY.

HAHAHAHA

[amaretto1] 23/7/2020 20:43

And they are positioned long !

[amaretto1] 23/7/2020 20:42

I agree ... it's still not with out risks..Every one here thinks it's a sure fire one way bet .... But polar capital for one ... are no mugs in this sector They know there onions !! :-)

[paradise city] 23/7/2020 20:39

https://youtu.be/wqDd7ixh184

[paradise city] 23/7/2020 20:38

For Igw ...... enjoy !

[dovey21] 23/7/2020 20:34

There's very little effort required to understand it. It is the replenishment of Interferon B, a naturally produced substance in the lungs that is sadly wiped out by the CV19 virus allowing it to spread. By replenishing via a nebuliser, it aids to restore levels and to provide a barrier to the Virus from infecting cells. Efficacy levels on a P3 trial may increase a little or decrease a little but is still a 'must have ' treatment. I can't foresee many, if any safety related concerns/issues as it is a natural substance we all produce and need to fight infection. That's my take on it and, as experts both here on the boards and the world over are enthusiastic and supportive of this treatment...to me, it's a no brainer. As for those who question the findings...they're scientists! That is what they do! Doubt and then prove themselves wrong.

[1gw] 23/7/2020 20:12

Nobby, I happily admit to knowing very little about Synairgen. I jumped in on Monday because the initial increase in market cap seemed to me very little compared to what I thought had happened to some other pharma companies when they announced data on "treatments" with apparently much less efficacy than the headline in the SNG release, or preliminary vaccine results again with questionable efficacy.

The Q&A was a car crash, wasn't it? Perhaps they hadn't expected informed biotech journalists to be on the line, but they should have been able to answer direct questions about whether the primary endpoint had been met.

Maybe they will never do a Phase 3 themselves - like I say I don't know enough about the company or its management. But to an outsider it seems like an obvious option - take advantage of the shareprice increase to raise funds (placing) which would allow them to do a Phase 3, either because they wanted to do one, or because they wanted that as a credible negotiating ploy in licensing or sale discussions.

Since Monday, and particularly last night, I read some reactions on twitter biotech and there is some pretty harsh commentary out there from people with expertise. This focuses on the selective publishing of results, the poor Q&A, and one or two questions about the data they have published.

So I decided to take the short-term profit. It's a windfall since I was buying in on the back of the announcement, it wasn't a long-held position. I may well be back in when they publish the peer-reviewed full results, or indeed just as an attempt to trade it at some point. As far as I can see, it could go to the stars or it could crash back down to earth - and I'm happy walking away for now with a material gain.

[nobbygnome] 23/7/2020 20:10

Well that proves you don't understand the ordinal scale..... Richard makes it clear in his answer but you can't see the wood for the trees.

I have tried to explain to you before so I am not going to bother again.

[supernumerary] 23/7/2020 20:08

If you say so. However, I base my opinions on what the company says, not your interpretation of the ordinal scale.

This is a transcript of part of the Bloomberg interview. The word 'Yes' does not appear, just as the word 'primary' does not appear in the RNS. Not on the ordinal scale, I suppose :¬)

You're talking your book, Nobby, as always...

---------------

Interviewer:
Do you know if the trial actually met its primary endpoint? Where are we? Give us a little bit of flavor of what you think happens next...

RM:
Well we are pleased with the data, and it's you know that protective effect that you just described, but also at the other end of the scale on the primary endpoint that we were assessing this ordinal scale which was proposed by WHO back in February and March as the endpoint to use. We also improved the chance that you can recover back to a level of no limitation of activities or better with this drug. So we couldn't have asked for more from this trial. And your question is a very good question and I have to put that to the agencies. And until we've got that information it would be wrong for me to speculate.

[bmwman3] 23/7/2020 20:02

I think it's a great intervention ew for sng

[bobaxe1] 23/7/2020 19:59

Another professor said this What is encouraging from the data, however, is that all the endpoints went in the same direction: recovery rate was greater (again limited to the treatment period only, which is artificial), and breathlessness was markedly reduced (highly significant statistically